Bone Health in Celiac Disease. Partha S. Sinha MD, PhD October 29 th, 2017

Similar documents
AACE/ACE Osteoporosis Treatment Decision Tool

Osteoporosis and Lupus. Andrew Ruthberg, MD University Rheumatologists

Osteoporosis. Definition

Osteoporosis Treatment Overview. Colton Larson RFUMS October 26, 2018

Osteoporosis Agents Drug Class Prior Authorization Protocol

John J. Wolf, DO Family Medicine

1

The Bare Bones of Osteoporosis. Wendy Rosenthal, PharmD

Reducing the Risk of Bone Fracture. A Review of the Research for Adults With Low Bone Density

What is Osteoporosis?

Pharmacy Management Drug Policy

Osteoporosis in Men Wendy Rosenthal PharmD. This program has been brought to you by PharmCon

Osteoporosis: Are your bones at risk of fracturing? Rachel Wallwork, MD Internal medicine resident Massachusetts General Hospital

This Coverage Policy applies to Individual Health Insurance Marketplace benefit plans only.

This information describes calcium supplements and how to take them.

Osteoporosis challenges

Hyperparathyroidism: Operative Considerations. Financial Disclosures: None. Hyperparathyroidism. Hyperparathyroidism 11/10/2012

Pharmacy Management Drug Policy

Osteoporosis/Fracture Prevention

Forteo (teriparatide) Prior Authorization Program Summary

FORTEO (teriparatide) INJECTION

Chau Nguyen, D.O. Rheumatologist Clinical Assistant Professor of Internal Medicine at Western University of Health Sciences

Pharmacy Management Drug Policy

OSTEOPOROSIS AND WHAT TO DO AFTER A VERTEBRAL FRACTURE. Lydia Au Geriatrics Ng Teng Fong Hospital

The Osteoporosis Center at St. Luke s Hospital

Clinician s Guide to Prevention and Treatment of Osteoporosis

Update on Osteoporosis 2016

Osteoporosis. Current Trend in Osteoporosis Management for Elderly in HK- Medical Perspective. Old Definition of Osteoporosis

This information describes calcium supplements and how to take them.

OSTEOPOROSIS IN MEN. Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO

OSTEOPOROSIS: PREVENTION AND MANAGEMENT

Osteoporosis. When we talk about osteoporosis, we have to be familiar with the constituents of bone and what it is formed of.

NEW DEVELOPMENTS IN OSTEOPOROSIS: SCREENING, PREVENTION AND TREATMENT

Osteoporosis Clinical Guideline. Rheumatology January 2017

BMD: A Continuum of Risk WHO Bone Density Criteria

AETNA BETTER HEALTH Prior Authorization guideline for Injectable Osteoporosis Agents

Osteoporosis Management

MAKE NO BONES ABOUT IT: UNDERSTANDING THE PHARMACIST S ROLE IN OSTEOPOROSIS MANAGEMENT. Jill Hiers, Pharm.D., BCPS

Marcy B. Bolster, MD Associate Professor of Medicine Division of Rheumatology Endocrine Associates Massachusetts General Hospital

OSTEOPOROSIS MEDICINES

Guideline for the investigation and management of osteoporosis. for hospitals and General Practice

4.7 Studies of Quality Holy Cross Hospital Bone Health Early Stage I ER/PR Positive Breast Cancer Patients December 13, 2017

Bisphosphonates. Making intelligent drug choices

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS

Aromatase Inhibitors & Osteoporosis

Bone Health for Women: Current Research, Initiatives and Recommendations

Men and Osteoporosis So you think that it can t happen to you

Medical Review. The following slides were medically reviewed by Dr. Nancy Dawson in June 2018.

This house believes that HRT should be the first-line prevention for postmenopausal osteoporosis: the case against

Osteoporosis - New Guidelines. Michelle Glass B.Sc. (Pharm) June 15, 2011

Management of postmenopausal osteoporosis

Osteoporosis/Fracture Prevention Clinician Guide SEPTEMBER 2017

Osteoporosis. Skeletal System

Prevalence of Osteoporosis 5/3/2017. Rhiannon Anderson, PA-C, FLS Linda Mitchell, PA-C, FLS, DEXA Specialist

DISCLAIMER DO NOT DISTRIBUTE

Parathyroid Hormone Analog for Osteoporosis Prior Authorization with Quantity Limit Criteria Program Summary

Osteoporosis Update. Greg Summers Consultant Rheumatologist

Vitamin D Hormone Du Jour

Learning Objectives. Osteoporosis: Lest We Forget Secondary Causes. Question 1: (USPSTF) Screening (DEXA) A few words about DEXA scans

V t i amin i n D a nd n d Calc l iu i m u : Rol o e l in i n Pr P eve v nt n io i n and n d Tr T eatment n of o Fr F actur u es and n d Fa F ll l s

Calcium Nephrolithiasis and Bone Health. Noah S. Schenkman, MD

New 2010 Osteoporosis Guidelines: What you and your health provider need to know QUESTIONS&ANSWERS

Introduction with terms of use agreement

Kristen M. Nebel, DO PENN/ LGHP Geriatrics. Temple Family Medicine Review

Sarena Ravi MD, MPH Endocrinologist. Franciscan Physicians Network Division of Endocrinology Chicago, IL

Osteoporosis for the PCP and consultant COPYRIGHT. Harold Rosen, MD Director- Osteoporosis Prevention and Treatment Center

New Developments in Osteoporosis: Screening, Prevention and Treatment

Talking to patients with osteoporosis about initiating therapy

Clinical Practice. Presented by: Internist, Endocrinologist

Vitamin D Replacement ROCKY MOUNTAIN MEETING NOV 2013 BANFF W.COKE UNIVERSITY OF TORONTO

Page 1. Updates in Osteoporosis. I have no conflicts of interest. What is osteoporosis? What s New in Osteoporosis

Session 4: New Evidence-Based Clinical Prac ce Guidelines B: Management of Osteoporosis in Post-Menopausal Women 4:15pm - 5:15pm

Cortical bone After age 40, gradually decreases % yearly, in both men and women Postmenopausally, loss accelerates to 2-3% yearly

Keeping old bones from breaking: The diagnosis, prevention, and treatment of osteoporosis

COURSE OUTLINE - Module I

Disclosure and Conflicts of Interest Steven T Harris MD Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis

Osteoporosis. Treatment of a Silently Developing Disease

Englewood Orthopedic Associates 401 South Van Brunt Street Englewood, NJ Tel: Fax: Jessica Fleischer, MD

Current and Emerging Strategies for Osteoporosis

Download slides:

Approval of a drug under this criteria document does not ensure full coverage of the drug.

Bone Densitometry Pathway

SpongeBone Menopants*

Steven W. Ing, M.D., MSCE Assistant Professor of Internal Medicine

Prevention of Osteoporotic Hip Fracture

Objectives: What is Osteoporosis 10/8/2015. Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING

Osteoporosis. Overview

Beyond the Break. After Breast Cancer: Osteoporosis in Survivorship. Dr Alexandra Ginty CCFP(EM) FCFP Regional Primary Care Lead CCO

Calcium metabolism and the Parathyroid Glands. Calcium, osteoclasts and osteoblasts-essential to understand the function of parathyroid glands

Page 1

Horizon Scanning Technology Briefing. Zoledronic Acid (Aclasta) once yearly treatment for postmenopausal. National Horizon Scanning Centre

Agents that Affect Bone & Mineral Homeostasis

Name of Policy: Zoledronic Acid (Reclast ) Injection

Guidelines for the Pharmaceutical Management of Osteoporosis in Adult WA Public Hospitals

Focusing on the Patient: Diagnosis and Management of Osteoporosis

Page 1. New Developments in Osteoporosis. What s New in Osteoporosis

Pathway from Fracture or Risk Factor to Treatment

OSTEOMALACIA UPDATE. Nothing to Disclose. Daniel D Bikle, MD, PhD Professor of Medicine University of California and VA Medical Center San Francisco

Updates in Osteoporosis

Transcription:

Bone Health in Celiac Disease Partha S. Sinha MD, PhD October 29 th, 2017

No Disclosures

Objectives Recognize the mechanisms by which celiac disease can affect bone health Review what diagnostic tests are useful Understand the role of nutrition and proper supplementation Gain awareness when pharmacologic or other intervention may be needed

Celiac Disease Intestinal disorder characterized by auotimmune reaction to gliadin fraction of gluten Associated with human leucoctye antigen (HLA) genes Multiple non intestinal manifestations Type 1 Diabetes Thyroiditis/Hypothyroidism Metabolic bone disease

Prevalance of bone disease in celiac Low bone density is more prevalent Kemppainen, Bone 1999

Celiac Disease and Fracture Risk Fracture risk appears modestly higher West, Gastroenterology 2003

Why does celiac disease affect bone? Calcium Vitamin D? Inflammation Image from: Dickey, Scand J Gastroenterol 2011

Calcium and Bone Avg human with ~ 1 kg of calcium 99% in bone Essential for bone strength Image from: Poole, PLoS One 2011 Emkey, Endocrinol Metab Clin N Am 2012

Osteomalacia Calcium deficiency can lead to bone demineralization A distinct mechanism from osteoporosis Image from: Jones, J Musculoskel Med 2009 Emkey, Endocrinol Metab Clin N Am 2012

Calcium Absorption Primarily in intestine duodenum Vitamin D has essential role Khanal, Ann Rev Nutr 2008 Image from: The American Heritage Medical Dictionary. 2007

Calcium Homeostasis PTH PTH Vit D Ca 2+ Images from: The American Heritage Medical Dictionary. 2007 Potts, Harrison s Principles of Internal Medicine 2014

Calcium Malabsorption in Celiac Disease Villous atrophy less surface area for absorption Intestinal Inflammation Loss of calcium transport proteins Impaired Vitamin D absorption Particularly if fat malabsorbed Krupa-Kozak, Nutrition 2014

Celiac Disease Villous Atrophy Normal Celiac Kambol, Clin Trans Gastroenterol, 2014

Calcium Malabsorption in Celiac Disease PTH Ca 2+ Vit D Potts, Harrison s Principles of Internal Medicine 2014 Krupa-Kozak, Nutrition 2014 Ca 2+

Secondary Hyperparathyroidism in Celiac Disease Parathyroid gland key regulator of calcium balance In response to decreased calcium and vitamin D absorption, parathyroid glands react by removing calcium from bone Khanal, Ann Rev Nutr 2008 Potts, Harrison s Principles of Internal Medicine 2014

Calcium Malabsorption in Celiac Disease PTH Ca 2+ Vit D Direct Inflammatory Effects? Potts, Harrison s Principles of Internal Medicine 2014 Krupa-Kozak, Nutrition 2014 Ca 2+

How to assess risk to bone health Blood tests Bone densitometry Low impact fractures -this warrants more urgent attention

Blood Tests Creatinine (kidney function) Calcium Vitamin D 25 OH Parathyroid hormone (PTH) Image from: mayomedicallaboratories.com

Serum Calcium Level Low serum calcium suggests deficiency High serum calcium needs further testing Normal serum calcium can be deceptive Ca 2+

24 Hour Urine Calcium More accurate reflection of calcium asborption Creatinine should be tested on same sample Image from: The Office 2010

Bone Densitometry (BMD) Surrogate for bone strength T score -1 to -2.5 osteopenia T score < -2.5 osteoporosis Spine and hip usually analyzed Melton, J Bone Miner Res 1992

When to get a BMD Consider doing after allowing for some time to treat the celiac disease and getting adequate calcium and vitamin D May do earlier in situations where osteoporosis medication may be needed Post menopausal -on glucocorticoids (steroids) High risk of fracture (type I diabetes, family history of hip fracture)

Treating Celiac Bone Disease Gluten Free Diet Calcium through diet and/or supplement Vitamin D Osteoporosis medications

Gluten Free Diet Improves BMD in children Recommended but may not be enough for the bone loss in adults Bianchi, Calcif Tissue Int 2002

Optimizing Calcium Intake 1200 mg calcium is RDA May be higher requirement in celiac disease Feasible to get via diet Yogurt: 300-450 mg Broccoli 70-100 mg Milk: 250-350 mg Tofu 300-450 mg

Calcium Supplements Fat Malabsorption (aka steatorrhea) Lactose Intolerance Diet too difficult

Calcium Supplements Calcium carbonate TUMS Caltrate -more common Not absorbed when on heartburn medication 500 mg Calcium Carbonate PIll Calcium Citrate Citracal 400 mg Calcium Citrate PIll

Assessing Calcium Intake Serum calcium (can be deceptive if normal) Parathyroid hormone level 24 hour urine calcium

Vitamin D and Bone Health Integral to calcium absorption and homeostasis May have direct role in bone formation and regneration Goltzman, Ann NY Acad Sci 2011 Lips, Best Pract Res Clin Endocr Metab 2011

Vitamin D More difficult to get via diet 400 to 2000 units vitamin D (presuming limited sun exposure) May need more if steatorhea/severe GI symptoms 50000 units vitamin D National Osteoporosis Foundation, 2013 Image from: webmd.com

Assessing Vitamin D Intake Replacement guided by serum levels Goal level > 30, though 20-30 may be acceptable

When Osteoporosis Medications If BMD T scores persistently below 2.5 Fragility fracture Post menopausal women Glucocorticoid Use Prednisone, solumedrol are Needed Other risk factors Family History Type I Diabetes Lee, Yonsei J Med 2011

Oral Bisphosphonates Alendronate (Fosamax) 70 mg weekly Risedronate (Actonel) 35 mg weekly or 150 mg monthly Ibandronate (Boniva) 150 mg monthly Rosen, UptoDate, 2014

If oral medication not tolerated or severe osteoporosis Zoledronate (Reclast) 5 mg yearly Denosumab (Prolia) 60 mg every 6 months No adjustment for renal insufficency Teriparatide (Forteo) 20 mcg SC daily Only anabolic agent Rosen, UptoDate, 2014

Osteoporosis Medications Ideally, calcium and vitamin intake should be optimized before starting these medications Possible risk of hypocalcemia with more potent medications Rosen, UptoDate, 2014

Conclusions

Celiac Disease Has Significant Impact on Bone Health PTH Ca 2+ Vit D Ca 2+ INFLAMMATION

Medical Testing Can Guide Maintenance of Bone Health Creatinine (kidney function) Calcium Vitamin D 25 OH Parathyroid hormone (PTH) 24 hour urine calcium Bone densitometry

Diet and supplements can make an May be higher requirement in celiac disease Feasible to get via diet, but pills can be effective if needed impact

Osteoporosis Medications May Sometimes Be Warranted Ultimate goal is to avoid fractures

Acknowledgments Harold Rosen, MD Alan Malabanan, MD Henry Kronenberg, MD Melinda Dennis, MS, RD, LDN National Celiac Association